Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries... Show more
Industry MedicalNursingServices
A.I.dvisor indicates that over the last year, BRKRP has been closely correlated with BRKR. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRKRP jumps, then BRKR could also see price increases.
| Ticker / NAME | Correlation To BRKRP | 1D Price Change % | ||
|---|---|---|---|---|
| BRKRP | 100% | -3.66% | ||
| BRKR - BRKRP | 91% Closely correlated | -4.34% | ||
| BIO - BRKRP | 40% Loosely correlated | -5.86% | ||
| PACB - BRKRP | 32% Poorly correlated | +5.91% | ||
| CNMD - BRKRP | 30% Poorly correlated | -0.65% | ||
| IART - BRKRP | 30% Poorly correlated | -1.17% | ||
More | ||||
BRKRP moved above its 50-day moving average on September 16, 2026 date and that indicates a change from a downward trend to an upward trend. In 4 of 4 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for BRKRP just turned positive on September 16, 2026. Looking at past instances where BRKRP's MACD turned positive, the stock continued to rise in 5 of 8 cases over the following month. The odds of a continued upward trend are 62%.
The 10-day moving average for BRKRP crossed bullishly above the 50-day moving average on September 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 2 of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +7.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRKRP advanced for three days, in 41 of 50 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 8 of 15 cases where BRKRP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 53%.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BRKRP as a result. In 9 of 15 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRKRP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
BRKRP broke above its upper Bollinger Band on September 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (10.853). P/E Ratio (0.000) is within average values for comparable stocks, (98.910). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). BRKRP's Dividend Yield (0.033) is considerably higher than the industry average of (0.002). P/S Ratio (0.000) is also within normal values, averaging (39.828).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. BRKRP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRKRP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.